219 related articles for article (PubMed ID: 20853353)
1. Rescue treatment by percutaneous closure of interatrial septal defect or PFO in infants with Berlin heart.
Gagliardi MG; Papavasileiou L; Pongiglione G
Catheter Cardiovasc Interv; 2011 Mar; 77(4):577-9. PubMed ID: 20853353
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
Johnson JN; Marquardt ML; Ackerman MJ; Asirvatham SJ; Reeder GS; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2011 Aug; 78(2):254-61. PubMed ID: 21563292
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Intervention to Treat Platypnea-Orthodeoxia Syndrome: The Toronto Experience.
Shah AH; Osten M; Leventhal A; Bach Y; Yoo D; Mansour D; Benson L; Wilson WM; Horlick E
JACC Cardiovasc Interv; 2016 Sep; 9(18):1928-38. PubMed ID: 27659570
[TBL] [Abstract][Full Text] [Related]
4. Hybrid peratrial double device closure of a patent foramen ovale and sinus venosus defect in an infant with vein of Galen malformation.
Delaney JW; Thorell WE; Hammel JM
Catheter Cardiovasc Interv; 2011 Dec; 78(7):1045-50. PubMed ID: 21542115
[TBL] [Abstract][Full Text] [Related]
5. Taming the "cobra": an approach to "cobra-like" formation seen in the Occlutech atrial septal defect and patent foramen ovale occluders.
Aaron S; Mainzer G; Lorber A
Catheter Cardiovasc Interv; 2012 Mar; 79(4):678-80. PubMed ID: 21805618
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism.
Bannan A; Shen R; Silvestry FE; Herrmann HC
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1066-9. PubMed ID: 19670302
[TBL] [Abstract][Full Text] [Related]
7. Interatrial shunt closure devices in patients with nickel allergy.
Reddy BT; Patel JB; Powell DL; Michaels AD
Catheter Cardiovasc Interv; 2009 Oct; 74(4):647-51. PubMed ID: 19777603
[TBL] [Abstract][Full Text] [Related]
8. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
Carroll JD
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
[No Abstract] [Full Text] [Related]
9. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
[TBL] [Abstract][Full Text] [Related]
10. Fracture of a GORE HELEX septal occluder following PFO closure in a diver.
Scott P; Wilson N; Veldtman G
Catheter Cardiovasc Interv; 2009 May; 73(6):828-31. PubMed ID: 19180658
[TBL] [Abstract][Full Text] [Related]
11. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous retrieval of the locked helex septal occluder.
Poommipanit P; Levi D; Shenoda M; Tobis J
Catheter Cardiovasc Interv; 2011 May; 77(6):892-900. PubMed ID: 20853357
[TBL] [Abstract][Full Text] [Related]
13. Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation.
Loar RW; Johnson JN; Cabalka AK; Cetta F; Hagler DJ; Eidem BW; Taggart NW
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1234-7. PubMed ID: 23239614
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series.
Rigatelli G; Dell'Avvocata F; Giordan M; Ronco F; Braggion G; Schenal N; Aggio S; Cardaioli P
J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):91-5. PubMed ID: 19829139
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
Majunke N; Wallenborn J; Wunderlich N; Sievert H
Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
[TBL] [Abstract][Full Text] [Related]
16. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
[TBL] [Abstract][Full Text] [Related]
18. Experience using the new GORE Septal Occluder at the margins.
Lockhart CJ; Johnston NG; Spence MS
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1244-8. PubMed ID: 23418128
[TBL] [Abstract][Full Text] [Related]
19. Defect closure in the lipomatous hypertrophied atrial septum with the Amplatzer muscular ventricular septal defect closure device: a case series.
Lin CH; Balzer DT; Lasala JM
Catheter Cardiovasc Interv; 2011 Jul; 78(1):102-7. PubMed ID: 21416575
[TBL] [Abstract][Full Text] [Related]
20. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
Luna M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
